SWHR announced the election of two new members to its Board of Directors: Dr. Linda G. Griffith and Dr. Michael Ybarra.
An SWHR working group published an expert review that identifies areas of need to improve a woman’s diagnosis, treatment, and access to quality care, as well as highlights priorities for the future of endometriosis research and care.
The Society for Women’s Health Research (SWHR) is pleased to announced the election of Alan Wright, MD, MPH, chief medical officer at Roche Diagnostics Corp., to its Board of Directors.
In an online survey developed by SWHR, a majority of school nurses reported that the pre-K-12 schools they work for do not have written policies on student bathroom use and do not have education for students and teachers on bladder health.
A new SWHR report highlights how improving our knowledge about sex differences in cell biology in the female and male lower urinary tract may help stimulate breakthroughs in the diagnosis and management of urinary dysfunction for both women and men.
To decrease the substantial health and economic burden of migraine, researchers need to address how the disease differs between women and men, according to a report from the Society for Women’s Health Research published in the Journal of Women’s Health.
To prevent and treat Alzheimer’s disease, scientists need to better understand how the disease differs between women and men, according to a paper published June 12 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
SWHR will honor Janet Woodcock, MD, of the Food and Drug Administration, Christi Shaw of Eli Lilly and Co., and Colleen Conway-Welch, PhD, of the Vanderbilt University School of Nursing with the Health Visionary Award at its 28th Annual Awards Dinner on May 1 at the InterContinental Washington D.C. - The Wharf.
SWHR announced the unanimous election of Roberta L. Gartside, MD, as the new Chair of its Board of Directors for 2018-2019. As a business leader with a strong commitment to nonprofit service, Dr. Gartside will lead the organization’s mission-based efforts to eliminate imbalances in care for women through science, advocacy, and education.
SWHR announced the election of two new members to its Board of Directors: Gretta Stone, Deputy Vice President of Policy & Research at PhRMA and Dawn Halkuff, Chief Commercial Officer at TherapeuticsMD.